Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Inflammation and Glycation in a General Adult Population (AES)

This study has been completed.
Information provided by (Responsible Party):
Francisco Gude, Hospital Clinico Universitario de Santiago Identifier:
First received: February 14, 2013
Last updated: May 21, 2015
Last verified: May 2015

Background. Obesity, insulin resistance and type 2 diabetes are closely associated with chronic inflammation characterized by abnormal cytokine production. Some authors have found discordances between glycated hemoglobin (HbA1c) and other measures of glycemic control, suggesting that a "glycation gap", defined as the difference between the HbA1c concentration and that predicted by the fructosamine concentration, could explain the excess interindividual variation in HbA1c.

The present study was aimed to examine the association between inflammation, sociodemographic (age, gender) and lifestyle factors (diet, exercise, alcohol, and tobacco consumption), and common diseases. In addition, we also examine levels of blood glucose, HbA1c, fructosamine and "glycation gap" determining the prevalence of "high glycators" in a general adult population and their association with lifestyles and prevalent diseases.

Methods. Selection of a random sample of the general adult population from a single municipality (A-Estrada, Pontevedra, Spain), stratified by age. The initial sampling includes 3,500 subjects. Considering approximate 67% participation rate, the final study population would include more than 2,000 individuals. The standard workup includes structured questionnaires, skin prick test, periodontal examination, psychological tests, physical examination and blood determinations to allow for categorization of participants in terms of basic demographics, profession, education level, socioeconomic level, quality of life, physical activity, diet, alcohol consumption and smoking, atopy, obesity, diabetes, metabolic syndrome, hypertension, cardiovascular disease, and liver disease. We determine blood levels of inflammation markers, HBA1c, fructosamine and glucose. We will collect a urine sample for microalbuminuria determination. In addition, blood will be drawn to be stored at the Biobank of our Hospital. One half of participants (~1000 individuals) will undergo continuous glucose monitoring. The design is cross-sectional, followed by a longitudinal study using population registries for the determination of events (mortality).

Discussion. This comprehensive study in a general adult population provides an excellent opportunity to determine serum concentrations of inflammation and glycation markers and how they can vary widely with age, sex, common habits, metabolic abnormalities, and chronic diseases. The findings from this study should also help to find out the relationship between glucose profiles and HbA1c and fructosamine concentrations with diet and inflammation markers.

Keywords: Inflammation, glycation, glycated hemoglobin, glycation gap, continuous glucose monitoring, obesity, allergy, periodontal diseases, depression, metabolic diseases.


Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Inflammation and Glycation in a General Adult Population

Further study details as provided by Hospital Clinico Universitario de Santiago:

Primary Outcome Measures:
  • Glycation gap levels [ Time Frame: At time of interview and after one week ]
    The glycation gap is calculated as the difference between measured HbA1c and predicted HbA1c from the fructosamine and glucose levels.

Secondary Outcome Measures:
  • Interstitial glucose levels [ Time Frame: 6 days ]

Biospecimen Retention:   Samples With DNA
whole blood, serum

Enrollment: 1516
Study Start Date: November 2012
Study Completion Date: March 2015
Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

This cross-sectional is being performed in the municipality of A-Estrada, in Northern Spain.

An age-stratified random sample of the population 18 years and older was drawm from the National Health System Registry


Inclusion Criteria:

  • Female or male
  • 18 years and older
  • No evidence of acute illness, fever, undue stress

Exclusion Criteria:

  • Unable to give informed consent
  • Pregnant
  • Dementia
  • Terminal cancer
  • Allergy to adhesives
  • Any concomitant medical condition that would likely affect the evaluation of device performance
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01796184

Centro de Saúde A-Estrada
A Estrada, Pontevedra, Spain, 36680
Sponsors and Collaborators
Hospital Clinico Universitario de Santiago
Study Chair: Arturo Gonzalez-Quintela, PhD, MD Hospital Clinico Universitario de Santiago
Study Chair: Francisco Gude, MD, PhD Hospital Clinico Universitario de Santiago
  More Information

Responsible Party: Francisco Gude, PhD, MD, Hospital Clinico Universitario de Santiago Identifier: NCT01796184     History of Changes
Other Study ID Numbers: FIS11/02219
Xunta de Galicia; ISCIII ( Other Grant/Funding Number: 10CSA918028PR; PI11/02219; RD12/0005/0007 )
Study First Received: February 14, 2013
Last Updated: May 21, 2015

Keywords provided by Hospital Clinico Universitario de Santiago:
Continuous glucose monitoring
Adult population

Additional relevant MeSH terms:
Pathologic Processes processed this record on April 28, 2017